These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3590083)

  • 1. Zinc alters fibrin ultrastructure.
    Marx G; Hopmeier P; Gurfel D
    Thromb Haemost; 1987 Feb; 57(1):73-6. PubMed ID: 3590083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elasticity of fibrin and protofibrin gels is differentially modulated by calcium and zinc.
    Marx G
    Thromb Haemost; 1988 Jun; 59(3):500-3. PubMed ID: 3187934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc inhibits FPA release and increases fibrin turbidity.
    Marx G; Hopmeier P
    Am J Hematol; 1986 Aug; 22(4):347-53. PubMed ID: 3728455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin indirectly modulates fibrin and protofibrin ultrastructure.
    Marx G; Harari N
    Biochemistry; 1989 Oct; 28(20):8242-8. PubMed ID: 2605181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro.
    Brass O; Belleville J; Sabattier V; Corot C
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):689-97. PubMed ID: 8292718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
    Flood VH; Nagaswami C; Chernysh IN; Al-Mondhiry HA; Weisel JW; Farrell DH
    Br J Haematol; 2007 Jul; 138(1):117-24. PubMed ID: 17555455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure.
    Henderson SJ; Xia J; Wu H; Stafford AR; Leslie BA; Fredenburgh JC; Weitz DA; Weitz JI
    Thromb Haemost; 2016 Mar; 115(3):533-42. PubMed ID: 26489782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
    Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
    Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional evaluation of an inherited abnormal fibrinogen: fibrinogen "Baltimore".
    Beck EA; Shainoff JR; Vogel A; Jackson DP
    J Clin Invest; 1971 Sep; 50(9):1874-84. PubMed ID: 5564395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalent cations induce protofibril gelation.
    Marx G
    Am J Hematol; 1988 Feb; 27(2):104-9. PubMed ID: 3341371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin clot structure in patients with end-stage renal disease.
    Sjøland JA; Sidelmann JJ; Brabrand M; Pedersen RS; Pedersen JH; Esbensen K; Standeven KF; Ariëns RA; Gram J
    Thromb Haemost; 2007 Aug; 98(2):339-45. PubMed ID: 17721616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
    Undas A; Kolarz M; Kopeć G; Tracz W
    Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of carboplatin with fibrin(ogen), implications for local slow release chemotherapy.
    Gorodetsky R; Peylan-Ramu N; Reshef A; Gaberman E; Levdansky L; Marx G
    J Control Release; 2005 Jan; 102(1):235-45. PubMed ID: 15653148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The procoagulant effect of zinc on fibrin clot formation.
    Marx G; Eldor A
    Am J Hematol; 1985 Jun; 19(2):151-9. PubMed ID: 4003387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen.
    Carr ME
    Thromb Haemost; 1988 Jun; 59(3):535-9. PubMed ID: 3187937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.